Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity

Objectives To assess clinical effectiveness, safety and in vivo effects on cytokines, chemokines and low-density neutrophils (LDNs) in patients with active systemic lupus erythematosus (SLE) treated with anifrolumab over a 12-month real-world follow-up.Methods We established a longitudinal, multicen...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Georg Schett, Filippo Fagni, Melanie Hagen, Luis E Muñoz, Axel J Hueber, Koray Tascilar, Andreas Wirsching, Rita Noversa de Sousa, Giulia Corte, Alp Temiz, Janina Schoen, Clara Reichardt, Kathrin Standfest, Marco Muñoz Becerra
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 2026-06-01
Serie:	RMD Open
Accesso online:	https://rmdopen.bmj.com/content/12/2/e006806.full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!